Replies to post #47060 on Xechem International Inc. (fka XKEM)

[silverfox1155]

I'm not really worried about additional non-dilutive financing. Many options available IMO. It's just a question of when. And that question can weigh on the PPS. Would hate to finalize an opinion and flip shares to buy back at a lower PPS and boom...a surprise could leave me dead in the water.

[smartmoney77]

'Africa mainly for Malaria and Aids business'

Just curious who told you that. Have you spoken to Howard?

[smartmoney77]

From my conversations the A/S has nothing to do with the loan or loan status at all! The loan may happen Monday or three weeks from Monday but the A/S increase is not needed for the loan to be approved. It is probably better to just call Xechem and ask Howard any questions of this sort. GLTY

[jranalyst]

Usually a banker wants to know how the loan will be repaid. They want collateral or a viable cash flow that demonstrates credit worthiness. Most bankers, imo, dont care if you have the best invention on earth, their first question is about how are you going to pay this loan back. A government guarantee is equally good, even from NEXIM.
I expect cash is flowing into the company already since they commercially launched the drug early in September. There should be an operations interim statement soon about sales. We need a status report. I am sure there will be a question about that at the meeting in Texas.
Secondly, no CEO wants to go into a shareholder meeting with empty hands. He wants the investors to applaud, not cut him up. I would expect he will have loan news even with a "subject to shareholder approval of increased A/S" by the shareholder meeting in October. Of course, next week would do fine. All imo.